Osteoblast differentiation and osteoclastogenesis assay in vitro

JM Jingjing Ma
SG Sheng Gao
XX Xiju Xie
ES Erhu Sun
MZ Min Zhang
QZ Qian Zhou
CL Cheng Lu
ask Ask a question
Favorite

Human mesenchymal stem cells (HMSCs) were purchased from ScienCell (Carlsbad, CA, USA), plated in cell culture flasks and expanded in mesenchymal stem cell growth medium (MSCM; ScienCell) at 37°C in a 5% CO2 atmosphere for 7–10 days. Subsequent to having grown to an adequate density (70–80% convergence), the adherent cells were trypsinized and seeded at a density of 5,000 cells/cm2 on a 24-well plastic plate. After 24 h, MSCM was removed, and osteogenic induction medium (ScienCell) was added to induce osteoblast differentiation (day 0). On the seventh day, the osteoblast cells were plated at 1×106 cells per well in 24-well plates, at a 1:1 ratio of basal culture medium/filtered CM (harvested from 24 h incubation of confluent tumor cells). The medium was replaced every 2 days. Tartrate-resistant acid phosphatase (TRAP) staining was performed on day 7 using a Leukocyte Acid Phosphatase kit from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany) (14). TRAP-positive multinucleated cells were considered mature osteoclasts and were included in the number of osteoclasts per well.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A